Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis.
暂无分享,去创建一个
C. Cambillau | L. Camoin | P. Fourquet | J. Cavalier | S. Canaan | V. Nguyen | Benjamin P. Martin | P. C. Nguyen | Chistopher D Spilling
[1] D. Hung,et al. The Expanding Diversity of Mycobacterium tuberculosis Drug Targets. , 2018, ACS infectious diseases.
[2] R. Miggiano,et al. Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets , 2018, Pathogens.
[3] N. Sampson,et al. Hit Generation in TB Drug Discovery: From Genome to Granuloma , 2018, Chemical reviews.
[4] L. Kremer,et al. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo , 2018, The Journal of Biological Chemistry.
[5] L. Kremer,et al. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases. , 2017, International journal of antimicrobial agents.
[6] L. Kremer,et al. Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis , 2017, Scientific Reports.
[7] Lisa K. Woolhiser,et al. Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13 , 2017, Cell.
[8] Faez Iqbal Khan,et al. The Lid Domain in Lipases: Structural and Functional Determinant of Enzymatic Properties , 2017, Front. Bioeng. Biotechnol..
[9] Natalie C. Sadler,et al. Systematic Survey of Serine Hydrolase Activity in Mycobacterium tuberculosis Defines Changes Associated with Persistence. , 2016, Cell chemical biology.
[10] L. Quadri,et al. Pleiotropic consequences of gene knockouts in the phthiocerol dimycocerosate and phenolic glycolipid biosynthetic gene cluster of the opportunistic human pathogen Mycobacterium marinum. , 2016, FEMS microbiology letters.
[11] C. M. Dupureur,et al. Synthesis and comparison of the biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of the natural AChE inhibitor cyclophostin. , 2015, Bioorganic & medicinal chemistry.
[12] C. M. Dupureur,et al. Rat hormone sensitive lipase inhibition by cyclipostins and their analogs. , 2015, Bioorganic & medicinal chemistry.
[13] M. Jackson. The mycobacterial cell envelope-lipids. , 2014, Cold Spring Harbor perspectives in medicine.
[14] A. Cazenave-Gassiot,et al. Targeting Lipid Esterases in Mycobacteria Grown Under Different Physiological Conditions Using Activity-based Profiling with Tetrahydrolipstatin (THL)* , 2013, Molecular & Cellular Proteomics.
[15] K. Holt,et al. Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans , 2013, Nature Genetics.
[16] K. Jaeger,et al. Structural and Functional Characterisation of TesA - A Novel Lysophospholipase A from Pseudomonas aeruginosa , 2013, PloS one.
[17] F. Carrière,et al. Enantioselective inhibition of microbial lipolytic enzymes by nonracemic monocyclic enolphosphonate analogues of cyclophostin. , 2013, Journal of medicinal chemistry.
[18] Alimuddin Zumla,et al. Advances in the development of new tuberculosis drugs and treatment regimens , 2013, Nature Reviews Drug Discovery.
[19] F. Carrière,et al. Synthesis and kinetic evaluation of cyclophostin and cyclipostins phosphonate analogs as selective and potent inhibitors of microbial lipases. , 2012, Journal of medicinal chemistry.
[20] Julien Leclaire,et al. MmPPOX Inhibits Mycobacterium tuberculosis Lipolytic Enzymes Belonging to the Hormone-Sensitive Lipase Family and Alters Mycobacterial Growth , 2012, PloS one.
[21] Garib N. Murshudov,et al. JLigand: a graphical tool for the CCP4 template-restraint library , 2012, Acta crystallographica. Section D, Biological crystallography.
[22] Peter J. Stuckey,et al. Automatic generation of protein structure cartoons with Pro-origami , 2011, Bioinform..
[23] Thomas R. Ioerger,et al. High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism , 2011, PLoS pathogens.
[24] G. D. de Souza,et al. A proteomic view of mycobacteria , 2011, Proteomics.
[25] Shaneen Singh,et al. Inactivation of tesA Reduces Cell Wall Lipid Production and Increases Drug Susceptibility in Mycobacteria* , 2011, The Journal of Biological Chemistry.
[26] L. Kremer,et al. A Mycobacterium marinum TesA mutant defective for major cell wall‐associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos , 2011, Molecular microbiology.
[27] F. Fotiadu,et al. Effects of Surfactants on Lipase Structure, Activity, and Inhibition , 2011, Pharmaceutical Research.
[28] T. Beddoe,et al. Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability* , 2010, The Journal of Biological Chemistry.
[29] G. Lambeau,et al. Two cutinase‐like proteins secreted by Mycobacterium tuberculosis show very different lipolytic activities reflecting their physiological function , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] Liisa Holm,et al. Dali server: conservation mapping in 3D , 2010, Nucleic Acids Res..
[31] D. Ollis,et al. α/βHydrolase Fold: An Update , 2009 .
[32] D. van Soolingen,et al. A Lipid Profile Typifies the Beijing Strains of Mycobacterium tuberculosis , 2009, The Journal of Biological Chemistry.
[33] Janet L. Smith,et al. Structure and Functional Analysis of RifR, the Type II Thioesterase from the Rifamycin Biosynthetic Pathway* , 2009, Journal of Biological Chemistry.
[34] André Lopez,et al. Phthiocerol Dimycocerosates of M. tuberculosis Participate in Macrophage Invasion by Inducing Changes in the Organization of Plasma Membrane Lipids , 2009, PLoS pathogens.
[35] M. Vasil,et al. Mycobacterium tuberculosis Rv3802c Encodes a Phospholipase/Thioesterase and Is Inhibited by the Antimycobacterial Agent Tetrahydrolipstatin , 2009, PloS one.
[36] E. Rubin,et al. Bacterial Growth and Cell Division: a Mycobacterial Perspective , 2008, Microbiology and Molecular Biology Reviews.
[37] B. Sapkota,et al. Role of PGL-I of M. leprae in TNF-alpha production by in vitro whole blood assay. , 2008, Nepal Medical College journal : NMCJ.
[38] G. Sciara,et al. A Topological Model of the Baseplate of Lactococcal Phage Tuc2009* , 2008, Journal of Biological Chemistry.
[39] Derek S. Tan,et al. Mycobacterial phenolic glycolipid virulence factor biosynthesis: mechanism and small-molecule inhibition of polyketide chain initiation. , 2008, Chemistry & biology.
[40] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[41] F. Carrière,et al. Effect of nonionic surfactants on Rhizopus homothallicus lipase activity , 2007, Molecular biotechnology.
[42] F. Carrière,et al. Exploring the specific features of interfacial enzymology based on lipase studies. , 2006, Biochimica et biophysica acta.
[43] D. Minnikin,et al. Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv , 2005, Letters in applied microbiology.
[44] G. Bricogne,et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. , 2004, Acta crystallographica. Section D, Biological crystallography.
[45] A. Ranganathan,et al. Interaction studies on proteins encoded by the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis , 2004, Molecular Genetics and Genomics.
[46] M. Reed,et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.
[47] E. Bradbury,et al. Comprehensive Proteomic Profiling of the Membrane Constituents of a Mycobacterium tuberculosis Strain*S , 2003, Molecular & Cellular Proteomics.
[48] R. Verger,et al. Inhibition of dog and human gastric lipases by enantiomeric phosphonate inhibitors: a structure-activity study. , 2003, Biochemistry.
[49] M. Daffé,et al. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. , 2002, The Journal of biological chemistry.
[50] L. Sarda,et al. Distinction between esterases and lipases: A kinetic study with vinyl esters and TAG , 2002, Lipids.
[51] P. Berna,et al. Crystal Structure of the Open Form of Dog Gastric Lipase in Complex with a Phosphonate Inhibitor* , 2002, The Journal of Biological Chemistry.
[52] B. Gicquel,et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. , 2001, The Journal of biological chemistry.
[53] H. Eickhoff,et al. Development of a technology for automation and miniaturization of protein crystallization. , 2001, Journal of biotechnology.
[54] B. Cravatt,et al. Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Verger,et al. Crystal Structure of Human Gastric Lipase and Model of Lysosomal Acid Lipase, Two Lipolytic Enzymes of Medical Interest* , 1999, The Journal of Biological Chemistry.
[56] B. Gicquel,et al. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope , 1999, Molecular microbiology.
[57] G. Besra,et al. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. , 1997, Science.
[58] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[59] C Cambillau,et al. Cutinase, a lipolytic enzyme with a preformed oxyanion hole. , 1994, Biochemistry.
[60] P. Højrup,et al. Rapid identification of proteins by peptide-mass fingerprinting , 1993, Current Biology.
[61] H. Tilbeurgh,et al. Interfacial activation of the lipase–procolipase complex by mixed micelles revealed by X-ray crystallography , 1993, Nature.
[62] R. Verger,et al. Competitive inhibition of lipolytic enzymes. I. A kinetic model applicable to water-insoluble competitive inhibitors. , 1990, Biochimica et biophysica acta.
[63] M. Daffé,et al. Structure of the major triglycosyl phenol-phthiocerol of Mycobacterium tuberculosis (strain Canetti). , 1987, European journal of biochemistry.
[64] F. Carrière,et al. New lipase assay using Pomegranate oil coating in microtiter plates. , 2016, Biochimie.
[65] P. Afonine,et al. research papers Acta Crystallographica Section D Biological , 2003 .
[66] Vincent B. Chen,et al. Acta Crystallographica Section D Biological , 2001 .
[67] R. Verger,et al. Interfacial enzyme kinetics of lipolysis. , 1976, Annual review of biophysics and bioengineering.